Dr. Ravindra Pandey

Distinguished Roswell Park Researcher Named Fellow of The National Academy of Inventors

Dr. Ravindra Pandey is a pioneer in photodynamic therapy, a cancer therapy developed at Roswell Park

  • Dr. Pandey on staff at Roswell Park for more than three decades
  • Has published 300+ research papers, holds 41 patents
  • Distinction among the highest awarded to academic inventors

BUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center congratulates Director of Pharmaceutical Chemistry Ravindra Pandey, PhD, for being named a National Academy of Inventors (NAI) Fellow.

Nationally recognized as one of “the highest distinctions awarded to academic inventors,” NAI Fellowship was newly awarded to 162 individuals who collectively hold more than 4,600 U.S. patents. The organization was founded to recognize such inventors and educate the public on how its members and their ideas benefit society. 

At the forefront of research in the field of photodynamic therapy (PDT) — a targeted treatment approach pioneered at Roswell Park — for more than three decades, Dr. Pandey has published more than 300 research papers and holds 41 patents. PDT is FDA-approved to treat several cancer types. The NAI Fellows Selection Committee chose Dr. Pandey for his “spirit of innovation” and inventions “that have made a tangible impact on the quality of life, economic development, and welfare of society.”

“This year’s class of NAI Fellows showcases the caliber of researchers that are found within the innovation ecosystem. Each of these individuals are making significant contributions to both science and society through their work,” says Dr. Paul R. Sanberg, Fellow and President of NAI. “This new class, in conjunction with our existing Fellows, are creating innovations that are driving crucial advancements across a variety of disciplines and are stimulating the global and national economy in immeasurable ways as they move these technologies from lab to marketplace.”

Dr. Pandey is the founder of Roswell Park spinoff company Photolitec LLC and a past winner of several Western New York Inventor of the Year Awards. He earned his doctorate from the University of Rajasthan in Jaipur, India.


From the world’s first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide. Driven to eliminate cancer’s grip on humanity, the Roswell Park team of 4,000 makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Founded in 1898, Roswell Park was among the first three cancer centers nationwide to become a National Cancer Institute-designated comprehensive cancer center and is the only one to hold this designation in Upstate New York. To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit www.roswellpark.org, call 1-800-ROSWELL (1-800-767-9355) or email ASKRoswell@RoswellPark.org.

Media Contact

Rebecca Vogt, Media Relations Specialist
716-845-4919; rebecca.vogt@roswellpark.org